GlassScriptPhysician profile
Everett Rogers
NPI 1235758699
$3,278.49
in general payments reported to CMS, 2019-2025
21 companies · $1,288 in 2025
The $1,288 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.34 · 2022: $200 · 2023: $396 · 2024: $1,356 · 2025: $1,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,771 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,770.51 |
| Education | $269.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $924.13 | 2024-2025 | Ensite, Esprit, Aveir |
| Boston Scientific Corporation | $746.58 | 2022-2025 | General - Therapies, Eluvia, Emblem Mri S-Icd |
| Shockwave Medical, INC | $358.40 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $295.68 | 2024 | Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $175.57 | 2024-2025 | |
| Abiomed | $118.10 | 2024 | Impella |
| Livanova USA, INC. | $108.71 | 2023 | Lifesparc |
| Medtronic, INC. | $89.18 | 2024-2025 | Symplicity G3, Aurora Ev-Icd Mri Surescan |
| Cardiva Medical, INC. | $65.45 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bayer Healthcare Pharmaceuticals INC. | $59.59 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $58.45 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $56.72 | 2024 | Crosser Iq |
| Actelion Pharmaceuticals US, INC. | $43.30 | 2024-2025 | Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.81 | 2024 | Jardiance |
| Biosense Webster, INC. | $30.48 | 2025 | Na |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $23.97 | 2025 | Glidesheath Slender |
| Teleflex LLC | $22.11 | 2025 | Vascband |
| Janssen Pharmaceuticals, INC | $18.64 | 2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.64 | 2021 | |
| Glaxosmithkline, LLC. | $16.55 | 2025 | Shingrix, Arexvy |
| Amgen INC. | $15.43 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Everett Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.